Simparica Trio

Description:

Simparica Trio is the first and only monthly parasiticide chew with moxidectin.

Simparica Trio provides triple protection against fleas and ticks, intestinal worms and deadly heartworm disease. It is uniquely formulated with an optimised trio of ingredients, including sarolaner, pyrantel and moxidectin, for proven efficacy against parasites.  

Simparica Trio complements your vet-exclusive ProHeart SR-12 business by providing you and your clients with both a monthly and yearly heartworm preventative option, both containing moxidectin for proven efficacy against heartworm. Simparica Trio is ideal for clients with dogs that are younger than when you start ProHeart SR-12 or for those who prefer a monthly oral combination parasiticide for their dog.

Recommendations for use:

For the treatment and control of fleas, ticks and gastrointestinal worms and the prevention of heartworm disease in dogs and puppies from 8 weeks of age.

SDS

• Rapidly kills fleas before they lay eggs
• Controls flea allergy dermatitis
• Treats and controls paralysis and brown dog ticks
• Prevents heartworm disease with monthly administration
• Treats and controls hookworms and roundworms, including adult and immature stages
• Liver flavoured chew

For oral use. Chews (chewable tablets) can be administered with or without food.

Simparica Trio is a tasty liver-flavoured chew which is readily consumed by the majority of dogs when offered as a treat. If the chew is not taken voluntarily by the dog, then it can also be given with a small amount of food or directly into the mouth.

Simparica Trio should be administered monthly. One chew per month based on the appropriate variant by weight range for the dog.

For dogs over 60kg, use an appropriate combination of chews based on the dog’s body weight.

Treatment Schedule:

For optimal treatment and control of fleas and tick infestations, the product should be administered at regular monthly intervals. Treatment with Simparica Trio may begin at any time of the year and should continue without interruption all year round. To minimise the likelihood of flea re-infestation, it is important to treat all dogs and cats within the household. Simparica Trio is approved for use in dogs only. Treatment for heartworm should occur regularly at monthly intervals.

Accidental ingestion of Simparica Trio may be harmful to children. To avoid accidental ingestion, administer the product immediately after its removal from the blister packaging. If the product is accidentally swallowed, seek medical advice immediately and show the package leaflet or label to the doctor. Keep the product in the original packaging until ready for use to prevent access by children. Used packaging should be disposed of immediately. Do not swallow. Wash hands after use.

Additional user safety:

Additional information is listed in the safety data sheet (SDS).

First Aid Statement

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.

Accidental ingestion of Simparica Trio may be harmful to children. To avoid accidental ingestion, administer the product immediately after its removal from the blister packaging. If the product is accidentally swallowed, seek medical advice immediately and show the package leaflet or label to the doctor. 

Keep the product in the original packaging until ready for use to prevent access by children. 

Used packaging should be disposed of immediately.

Can be safely given to: -

• dogs from 1.25kg and 8 weeks of age
• heartworm positive dogs

Well tolerated in avermectin sensitive dogs

Can be used concurrently with – anaesthetics, anthelmintics, antibiotics, anti-inflammatories, parasiticides and vaccines.

Not recommended for use on puppies under 8 weeks old or weighing less than 1.25 kg. Do not use in cases of hypersensitivity to the active substances. The safe use of Simparica Trio has not been evaluated in breeding dogs and pregnant or lactating bitches. 

Simparica Trio has been shown to be safe in various breeds of dog across a broad weight range when administered according to the dosage schedule.